Reprogramming, Justice and Rawls

A conversation with George Daley

Date:	November 6, 2009
Speakers:	George Daley
Topics:	CIRM, Disease, Ethics, Reprogramming, Stem Cells, iPS Stem Cells

<Embed>	Copy the embed code below to post this video in your site.
<object width='450' height='274' name='internal' id='internal'> <param name='movie' value='http://thesciencenetwork.org/player.swf'> <param name='allowfullscreen' value='true'> <param name='allowscriptaccess' value='always'> <param name='wmode' value='transparent'> <param name='flashvars' value='file=http://thesciencenetwork.org/media/videos/455.flv&skin=http://thesciencenetwork.org/flash/bluemetal/bluemetal.swf&image=http://thesciencenetwork.org/media/videos/455.jpg'> <embed type='application/x-shockwave-flash' name='internal' id='internal' src='http://thesciencenetwork.org/player.swf' width='450' height='274' bgcolor='#ffffff' allowscriptaccess='always' allowfullscreen='true' flashvars='file=http://thesciencenetwork.org/media/videos/455.flv&skin=http://thesciencenetwork.org/flash/bluemetal/bluemetal.swf&image=http://thesciencenetwork.org/media/videos/455.jpg' /> </object>

Audio Podcast:	Subscibe with iTunes Or, copy and paste this URL into a podcasting tool:

George Daley is Samuel E Lux, IV Chair in the Department of Hematology, Associate Professor of Biological Chemistry, Molecular Pharmacology and of Pediatrics at Harvard Medical School. He is the Director of the Stem Cell Transplantation Program at Children’s Hospital Boston and an Investigator of the Howard Hughes Medical Institute. Daley’s research is focused on development, cellular reprogramming, disease processes and the improvement of therapeutics with an emphasis on leukemia and genetic blood disorders.